Nitric oxide therapy

University HealthSystem Consortium
Record ID 32000008213
Authors' objectives:

Analyzes nitric oxide (NO) therapy, which is used primarily to treat patients with pulmonary hypertension. Although the FDA has not yet approved NO for use in humans, current evidence suggests that NO therapy is safe and effective. Key studies and case reports focusing on the clinical efficacy and utility of NO therapy are reviewed, and discussion of adverse effects, administration and monitoring, and cost issues is also provided. Results of a survey of UHC members on issues related to NO therapy are also included.

Authors' methods: Overview
Project Status: Completed
URL for project:
Year Published: 1996
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Hypertension, Pulmonary
  • Nitric Oxide
Organisation Name: University HealthSystem Consortium
Contact Address: University HealthSystem Consortium, 2001 Spring Rd., Suite 700, Oak Brook, IL 60523 USA. Tel: 630-954-1700, Fax: 630/954-4730
Contact Name:
Contact Email:
Copyright: University HealthSystem Consortium
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.